Emicizumab plasma levels after accelerated saturation in acquired haemophilia A

Documenti analoghi

• Postpartum Acquired Hemophilia A in Two Women With Previously Undiagnosed Carrier Status for von Willebrand Disease Type 2N and Heterozygous p.R854Q Mutation
  di: Maria Weise, et al.
  Pubblicazione: (2026)
• Measurement of recombinant porcine factor VIII in patients with congenital haemophilia A and inhibitors in the presence of emicizumab
  di: Christian Pfrepper, et al.
  Pubblicazione: (2024)
• Recombinant porcine factor VIII in patients with congenital haemophilia A with inhibitors undergoing surgery: Phase 3, single‐arm, open‐label study
  di: Christian Pfrepper, et al.
  Pubblicazione: (2024)
• Emicizumab and asparaginase, A first experience to share
  di: Laurie Goubeau, et al.
  Pubblicazione: (2024)
• Challenges in ageing persons with haemophilia
  di: Michael Makris, et al.
  Pubblicazione: (2024)